[Skip to Content]
[Skip to Content Landing]
Article
July 28, 1993

Antimicrobial Therapy for Otitis Media With Effusion: The Pittsburgh Response-Reply

JAMA. 1993;270(4):450. doi:10.1001/jama.1993.03510040053017
Abstract

In Reply.  —Dr Cantekin has responded to virtually none of the substance of our article, but instead advances invalid accusations and other misleading statements.First, as for "special oversight," the OSI noted that "the recommendations concerning operations of the OMRC were not intended as sanctions..." but "were intended to provide safeguards against even the appearance of possible conflict of interest..."1(p3) The OSI did not find that Dr Bluestone had "financial ties to drug companies." Dr Bluestone had received research support from drug companies and honoraria for presentations at scientific and educational meetings, but the OSI did not find that these funds were "undisclosed." The OSI also did not find "bias."2Second, the OSI commentary on antibiotic therapy now cited by Cantekin referred not to our New England Journal of Medicine article3 that Cantekin and his coauthors had criticized4 and that our JAMA article defended, but rather

×